ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,753.70
0.35%
S&P ASX All Technology
3,050.50
0.56%
Brent Oil
82.575
0.03%
US Dollar vs AUD
1.50498
-0.31%
Bitcoin
62,185.97
1.03%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Heart Test Laboratories Inc (HSCS)

  7. Heart Test Laboratories Inc (HSCS) News

HSCS Heart Test Laboratories Inc

0.0791
0.00 (0.00%)
15 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Heart Test Laboratories Inc HSCS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 0.0791 10:00:00
Open Price Low Price High Price Close Price Previous Close
0.0791
more quote information »

Recent News

Date Time Source Heading
24/4/202423:00GLOBEHeartSciences Announces Grant of Fundamental Patent by the..
03/4/202407:15GLOBEHeartSciences to Present at the LD Micro Invitational XIV..
27/3/202400:00GLOBEHeartSciences Announces Podium Presentation at World..
15/3/202407:15GLOBEHeartSciences Reports Third Quarter Fiscal 2024 Financial..
13/3/202400:00GLOBEHeartSciences’ Announces Peer-Reviewed Publication..
07/3/202401:00GLOBEHeartSciences Announces Canada Patent Grant Covering..
06/3/202408:55EDGAR2Form S-1 - General form for registration of securities under..
27/2/202409:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202401:00GLOBEHeartSciences Adds Key Advisor to its Scientific Advisory..
16/2/202408:30EDGAR2Form 8-K - Current report
13/2/202401:00GLOBEHeartSciences Expands its Scientific Advisory Board
02/2/202401:00GLOBEHeartSciences Appoints New Scientific Advisory Board Member
01/2/202401:00EDGAR2Form 8-K - Current report
26/1/202400:59EDGAR2Form 8-K - Current report
19/1/202400:14EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/1/202400:11EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/1/202400:00GLOBEHeartSciences Announces Results and Adjournment of Annual..
18/1/202423:55EDGAR2Form 8-K - Current report
04/1/202408:15GLOBEHeartSciences Reminds Stockholders to Vote at the Upcoming..
15/12/202308:15GLOBEHeartSciences Reports Second Quarter Fiscal 2024 Financial..
15/12/202308:07EDGAR2Form 8-K - Current report
15/12/202308:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/12/202309:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/12/202300:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/12/202309:14EDGAR2Form DEF 14A - Other definitive proxy statements
08/12/202309:00EDGAR2Form D/A - Notice of Exempt Offering of Securities: [Amend]
07/12/202301:21EDGAR2Form 8-K - Current report
06/12/202300:00GLOBEHeartSciences Receives FDA Confirmation for 510(k) Clearance..
29/11/202309:26EDGAR2Form PRE 14A - Other preliminary proxy statements
28/11/202308:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/11/202300:30EDGAR2Form 8-K - Current report
22/11/202300:30EDGAR2Form 8-K - Current report
21/11/202300:00GLOBEHeartSciences Announces Closing of License Agreements with..
18/11/202308:51EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/11/202308:26EDGAR2Form 8-K - Current report
14/11/202300:45GLOBEHeartSciences’ MyoVista® wavECGTM Selected for Heart..
20/10/202300:00GLOBEHeartSciences Issues Investor Update Highlighting Recent Key..
14/10/202312:36EDGAR2Form S-1/A - General form for registration of securities..
05/10/202308:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/9/202322:00GLOBEHeartSciences Receives Two New Patent Allowances, Expanding..
25/9/202322:00GLOBEHeartSciences to Participate in the Maxim Group Virtual Tech..
23/9/202306:16EDGAR2Form 8-K - Current report
21/9/202322:00EDGAR2Form 8-K - Current report
21/9/202322:00GLOBEHeartSciences Signs Definitive Agreements with the Icahn..
18/9/202320:09EDGAR2Form S-3 - Registration statement under Securities Act of..
15/9/202306:24EDGAR2Form 8-K - Current report
15/9/202306:15GLOBEHeartSciences Reports First Quarter Fiscal 2024 Financial..
15/9/202306:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/9/202306:15GLOBEHeartSciences to Present at the Gilmartin Group Emerging..
12/9/202306:15GLOBEHeartSciences Named Electrocardiography Advancement..

Your Recent History

NASDAQ
HSCS
Heart Test Laboratories
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved